The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status

Giuseppe Bronte; Tindara Franchina; Massimiliano Alù; Giovanni Sortino; Claudia Celesia; Francesco Passiglia; Giuseppina Savio; Agata Laudani; Alessandro Russo; Antonio Picone; Sergio Rizzo; Michele De Tursi; Elisabetta Gambale; Viviana Bazan; Clara Natoli; Livio Blasi; Vincenzo Adamo; Antonio Russo

doi:10.18632/oncotarget.8130

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status

Oncotarget ◽

10.18632/oncotarget.8130 ◽

2016 ◽

Vol 7 (24) ◽

pp. 35803-35812 ◽

Cited By ~ 5

Author(s):

Giuseppe Bronte ◽

Tindara Franchina ◽

Massimiliano Alù ◽

Giovanni Sortino ◽

Claudia Celesia ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Third Line

Download Full-text

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

BMC Cancer ◽

10.1186/1471-2407-11-1 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 81

Author(s):

Satoshi Watanabe ◽

Junta Tanaka ◽

Takeshi Ota ◽

Rie Kondo ◽

Hiroshi Tanaka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Clinical Responses

Download Full-text

Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib

Lung Cancer ◽

10.1016/j.lungcan.2005.07.012 ◽

2005 ◽

Vol 50 (3) ◽

pp. 393-399 ◽

Cited By ~ 9

Author(s):

Hideharu Kimura ◽

Kazuo Kasahara ◽

Masaru Sekijima ◽

Tomohide Tamura ◽

Kazuto Nishio

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Skin Toxicity ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

European Journal of Cancer ◽

10.1016/s0959-8049(11)72399-1 ◽

2011 ◽

Vol 47 ◽

pp. S618-S619

Author(s):

S. Watanabe ◽

Y. Saida ◽

K. Ichikawa ◽

J. Koshio ◽

J. Baba ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Clinical Responses

Download Full-text

PREDICTIVE FACTORS FOR LONG‐TERM RESPONDERS IN ADVANCED NON‐SMALL CELL LUNG CANCER PATIENTS TREATED WITH TYROSINE KINASE INHIBITOR

Respirology ◽

10.1111/resp.13700_281 ◽

2019 ◽

Vol 24 (S2) ◽

pp. 185-186

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Predictive Factors ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients

Lung Cancer ◽

10.1016/j.lungcan.2018.06.032 ◽

2018 ◽

Vol 123 ◽

pp. 60-69 ◽

Cited By ~ 19

Author(s):

Chong Hyun Suh ◽

Hye Sun Park ◽

Kyung Won Kim ◽

Junhee Pyo ◽

Hiroto Hatabu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Proposal of new CT response criteria in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7035 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7035-7035

Author(s):

H. Lee ◽

K. Lee ◽

M. Ahn ◽

H. Hwang ◽

J. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Predictive efficacy of11C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients

International Journal of Cancer ◽

10.1002/ijc.29832 ◽

2015 ◽

Vol 138 (4) ◽

pp. 1003-1012 ◽

Cited By ~ 9

Author(s):

Dong Dai ◽

Xiao-Feng Li ◽

Jian Wang ◽

Jian-Jing Liu ◽

Yan-Jia Zhu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Pet Imaging ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Efficacy and Safety of Lorlatinib in Korean Non–Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor

Clinical Lung Cancer ◽

10.1016/j.cllc.2018.12.020 ◽

2019 ◽

Vol 20 (3) ◽

pp. 215-221 ◽

Cited By ~ 3

Author(s):

Jiyun Lee ◽

Jong-Mu Sun ◽

Se-Hoon Lee ◽

Jin Seok Ahn ◽

Keunchil Park ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Ros1 Rearrangement

Download Full-text

Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?

Scientific Reports ◽

10.1038/srep05996 ◽

2014 ◽

Vol 4 (1) ◽

Cited By ~ 4

Author(s):

Ze-Rui Zhao ◽

Wei li ◽

Hao Long

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s143569 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4261-4267 ◽

Cited By ~ 1

Author(s):

Ling Peng ◽

Yina Wang ◽

Yemin Tang ◽

Lei Zeng ◽

Junfang Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text